Research Analysts’ upgrades for Tuesday, June 13th:

Aimmune Therapeutics (NASDAQ:AIMT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $20.00 target price on the stock. According to Zacks, “Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company’s characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and adults which is in clinical trial stage. Aimmune Therapeutics, Inc. is headquartered in Brisbane, California. “

Alimera Sciences (NASDAQ:ALIM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity. Its product candidate Iluvien(R) is an intravitreal insert containing fluocinolone acetonide, a non-proprietary corticosteroid with demonstrated efficacy in the treatment of ocular disease. Iluvien is in development for the treatment of diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. “

Anthera Pharmaceuticals (NASDAQ:ANTH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious illnesses, including cardiovascular and autoimmune diseases. The Company’s clinical-stage programs include one Phase 3 ready program, A-002, and two Phase 2 clinical programs, A-623 and A-001. A-002 and A-001 inhibit a novel enzyme target known as secretory phospholipase A2, or sPLA2. Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease. A-623 targets elevated levels of B-lymphocyte stimulator, or BLyS (also known as BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sj√∂gren’s Syndrome, Graves’ Disease and others. Anthera Pharmaceuticals, Inc. is headquartered in Hayward, California. “

ARC Group Worldwide (NASDAQ:ARCW) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “ARC Group Worldwide, Inc. is a diversified manufacturing holding company with operations in Colorado, Florida, Pennsylvania, Texas, Minnesota, China and Hungary. It provides wireless network component and wireless network solutions. The Company designs and develops hardware, including antennas, radios, and related accessories, used in broadband and other wireless networks. It supplies its products to public and private carriers, wireless infrastructure providers, wireless equipment distributors, value added resellers and other original equipment manufacturers. ARC Group Worldwide, Inc., formerly known as ARC Wireless Solutions Inc., is based in Denver, Colorado. “

Atmos Energy Corporation (NYSE:ATO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $94.00 target price on the stock. According to Zacks, “Atmos Energy Corporation distributes and sells natural gas to residential, commercial, industrial, agricultural and other customers. Atmos operates through five divisions in cities, towns and communities in service areas located in Colorado, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Missouri, South Carolina, Tennessee, Texas and Virginia. The Company has entered into an agreement to sell all of its natural gas utility operations in South Carolina. The Company also transports natural gas for others through its distribution system. “

Avery Dennison Corporation (NYSE:AVY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $94.00 price target on the stock. According to Zacks, “For 2017, Avery hiked adjusted earnings per share guidance to a range of $4.50–$4.65, reflecting a stronger operating outlook and a lower tax rate. Its consistent execution of strategies continues to enhance competitive advantage while driving profitable growth. Consistent focus on productivity, cost control and share repurchases will also drive results.  In sync with its strategy to expand in the medical sector, Avery Dennison has acquired Longford, Ireland-based Finesse Medical, a maker of materials used for wound care and skin treatments. Its shares have also outperformed the Zacks categorized Office Supplies & Forms sub industry year to date. However, choppy growth in Radio Frequency Identification products and raw material inflation remain near term concerns.”

Babcock Intl Group (NASDAQ:BCKIY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $12.00 target price on the stock. According to Zacks, “Babcock International Group PLC offers engineering support services to the defense, energy, emergency services, transport and education sectors. The Company’s operating segment consists of Marine and Technology, Defence and Security, Support Services and International. Marine and Technology segment offers engineering support services to the Royal Navy. Defence and Security segment provides to the United Kingdom’s armed forces, delivering technical training and asset management. Support Services segment manages assets, delivers programs and teaches vital skills for civil Governments and blue-chip commercial organizations. Mission Critical Services business is a provider of helicopter and fixed-wing emergency services and crew change services for oil and gas operators primarily in Europe and Australia. Babcock International Group PLC is headquartered in London, the United Kingdom. “

Barloworld Limited (NASDAQ:BRRAY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $10.00 target price on the stock. According to Zacks, “Barlow LTD is an international industrial brand management company that achieves durability in business through long-term value creation. Barlow represents many of the world’s greatest brands in the marketplace. They provide the vital link between manufacturer and customer. They add value through sales, deliver after-market support and provide total solutions to their customers’ needs. Their brands include Caterpillar, Hyster, Perkins, Ditch Witch and many of the world’s leading automotive brands. “

Banco Santander-Chile (NASDAQ:BSAC) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $27.00 target price on the stock. According to Zacks, “Banco Santiago is the largest bank in Chile, in terms of assets with Ch$4,088 billion (approximately US$9.86 billion ) as of March 31, 1997. The bank is the result of the merger of two of the largest institutions in the Chilean banking system, Banco O’Higgins S.A., mainly a corporate bank, and Banco de Santiago S.A., mainly focused in consumer and middle-market lending. “

Carillion (NASDAQ:CIOIF) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $3.00 target price on the stock. According to Zacks, “Carillion plc provides an integrated support services company. The company’s service consists of support services, project finance and construction services. Support services provides maintenance, facilities management, energy and infrastructure services for roads, railways and utility networks, notably telecommunications and power transmission and distribution, and remote site accommodation services. Project finance arranges the funding for Public Private Partnership projects. It operates primarily in the United Kingdom, the Middle East and North Africa, Canada and the rest of the world. Carillion plc is headquartered in Wolverhampton, the United Kingdom. “

SEACOR Holdings (NYSE:CKH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $41.00 price target on the stock. According to Zacks, “SEACOR and its subsidiaries are engaged in the operation of a diversified fleet of offshore support vessels that service oil and gas exploration and development activities in the U.S. Gulf of Mexico, the North Sea, West Africa, Asia, Latin America and other international regions. Other business activities primarily include environmental services, inland river operations, and offshore aviation services. “

Credit Agricole Sa (NASDAQ:CRARY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $9.00 target price on the stock. According to Zacks, “Credit Agricole S.A. markets a complete range of financial products and services. It offers savings, investments, life insurance, credit, payment and insurance services. Its activities are organized into three business lines: Central body: it ensures the cohesion and smooth functioning of the network, and represents the Group with banking authorities; Specialized business: it provides asset management, insurance, private banking, consumer credit, leasing, factoring and Banking and investment. The strength of its retail bank and know -how of its subsidiaries enable it to intervene in all areas of banking and finance. Credit Agricole is headquartered in Paris, France. “

Digiliti Money (NASDAQ:DGLT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Digiliti Money Group, Inc. is a technology solutions and services provider to the financial services industry. The company operates as a cloud-based software-as-a-service provider of remote deposit capture and mobile wallet solutions for customers of banks, credit unions, prepaid card programs, check cashing services and payday lenders. Its solutions and services enable banks, credit unions and alternative financial services providers to offer their customers remote deposit capture and prepaid mobile money technologies and related services. Digiliti Money Group, Inc., formerly known as Cachet Financial Solutions, Inc., is headquartered in Minneapolis. “

ChannelAdvisor Corporation (NYSE:ECOM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $13.00 price target on the stock. According to Zacks, “Channel Advisor Corporation offers cloud-based e-commerce solutions and services. It solutions include marketplaces, comparison shopping, paid search, social campaigns, flex feeds, web stores and rich media. The company serves traditional retailers, online retailers, brand manufacturers and advertising agencies. Channel Advisor Corporation is headquartered in Morrisville, North Carolina. “

Exact Sciences Corporation (NASDAQ:EXAS) was upgraded by analysts at Vetr from a buy rating to a strong-buy rating. Vetr currently has $36.39 target price on the stock.

First Community Financial Partners (NASDAQ:FCFP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $15.00 price target on the stock. According to Zacks, “First Community Financial Partners, Inc. is a bank holding company which provides commercial, family and personal banking products and services. First Community Financial Partners, Inc. is headquartered in Joliet, Illinois. “

Finisar Corporation (NASDAQ:FNSR) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “FINISAR CORP. is a provider of fiber optic subsystems and network test and monitoring systems which enable high-speed data communications over local area networks, or LANs, storage area networks, or SANs, and metropolitan access networks, or MANs. They are focused on the application of digital fiber optics to provide aline of high-performance, reliable, value-added optical subsystems for data networking and storage equipment manufacturers. “

Twenty-First Century Fox (NASDAQ:FOX) was upgraded by analysts at Zacks Investment Research from a sell rating to a buy rating. The firm currently has $31.00 price target on the stock. According to Zacks, “Twenty-First Century Fox, Inc. is involved in creating and distributing media services. Its business portfolio consists of cable, broadcast, film, pay TV and satellite assets. Twenty-First Century Fox, Inc., formerly known as News Corporation, is based in New York, United States. “

Galectin Therapeutics (NASDAQ:GALT) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.75 target price on the stock. According to Zacks, “Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts. “

Receive News & Ratings for Aimmune Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimmune Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.